Abiopharma

News list

ADENT JOHN EDWARD 🟡 adjusted position in 0 shares (1 derivative) of NEOGEN CORP (NEOG) at $5.43 Filing ID: 000033

Full text

News bot Aug. 20, 2025, 6:50 p.m.
🔍 ADENT JOHN EDWARD (Executive)

Company: NEOGEN CORP (NEOG)

Report Date: 2025-08-18
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 35,736
- Total shares sold: 35,736
Detailed Transactions and Holdings:
- Acquired 35,736 shares of Common Stock at $5.43 per share (Direct)
  Date: 2025-08-18 | Code: M | equity_swap_involved: 0 | shares_owned_after: 307,012.00 | transaction_form_type: 4
- Sold 35,736 shares of Restricted Stock Units at $5.43 per share (Derivative)
  Date: 2025-08-18 | Code: M | Expires: 2025-08-18 | Exercise: 2025-08-18 | equity_swap_involved: 0 | shares_owned_after: 71,472.00 | transaction_form_type: 4